Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
Dr Gregory Smith has become the firm's chief medical cannabis advisor, said Callitas
It also has a strong, diverse economy with a broad base of entrepreneurs
The group reported further progress on its flagship product, namely FDA approval to sell its VMS Plus machine
Canntab says it will begin making the first pivotal batch of the product this week
The group’s VMS+ product is an artificial intelligence (AI) tool for measuring whole heart function
Shareholders approved the move at the AGM and special meeting of shareholders on May 14
The pot materials will be used in PreveCeutical's soluble gel (Sol-gel) drug delivery research...
Dr Piotr Witkowski is a widely published diabetes researcher and respected surgeon
Analyst Craig Stanley, back from a site visit, repeated a 'buy' on the stock
The Tiple Block acreage is adjacent to Geopark’s prolific Llanos 34 Block
A look at some of the analyst comment on North America listed stocks on Monday
A look at some analyst views from around the City on Friday